Causes and surgical treatment of diplopia and strabismus secondary to myasthenia gravis

• Published in: Archivos de la Sociedad Española de Oftalmología (English ed.) 2019-03, Vol.94 (3), p.107-113
• Main Authors: Merino Sanz, P, Del Cerro Pérez, I, Alan Peinado, G, Gómez de Liaño Sánchez, P
• Format: Article
• Language: eng ; spa
• ISSN: 2173-5794
• DOI: 10.1016/j.oftal.2018.11.007

OBJECTIVETo present a report of the ocular motility disorders, treatment and outcomes of myasthenia gravis (MG). MATERIAL AND METHODA retrospective study was performed on the data of patients with MG. An evaluation was made using mean age, gender, initial diagnosis, ocular deviation, time of onset of clinical characteristics, treatment and results. Resolution of diplopia and/or ocular deviation in primary and reading gaze was considered a good outcome at the end of follow-up. RESULTSA total of 14 cases were included. The mean age of the sample was 55.64 years, of which 9 were women, and 10 cases were bilateral. The diagnosis was made by ophthalmologists in 4 cases. The initial diagnoses were diverse: bilateral cranial third nerve palsy in 3, unilateral third nerve palsy in 1, superior or inferior rectus palsy in 3, sixth nerve palsy in 2, fourth nerve palsy in 1, exotropia in 3 and esotropia in 1. Diplopia was presented in 14 cases and 9 associated ptosis. The different types of strabismus were horizontal ocular deviation in 11 cases: 8 with exotropia, and 4 with vertical deviation. Strabismus surgery was performed in 4 cases that did not respond to medical treatment, with a good final outcome. Pharmacological treatment resolved diplopia in 6 cases, and prisms in one. Ptosis surgery was only necessary in one patient. Outcome was favourable in 78.57% at the end of follow-up. CONCLUSIONAcute onset diplopia caused by strabismus with variable angle or oculomotor palsy, associated or not with a ptosis can indicate MG. There were favourable outcomes with strabismus surgery. Pharmacological treatment did not resolve the diplopia in all cases.